Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Sumitomo Dainippon Pharma Co ( (JP:4506) ).
Sumitomo Pharma Co., Ltd. announced a reversal of allowance for doubtful accounts amounting to 46,556 million yen in its non-consolidated financial statements for the fiscal year ended March 31, 2025. This adjustment, recorded as extraordinary income, will not affect the company’s consolidated profit or loss as it will be eliminated in the consolidated financial statements.
More about Sumitomo Dainippon Pharma Co
Sumitomo Pharma Co., Ltd., based in Osaka, Japan, is a company engaged in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company operates globally, with a particular emphasis on innovative healthcare solutions.
YTD Price Performance: 15.33%
Average Trading Volume: 481
Technical Sentiment Signal: Buy
Current Market Cap: $1.88B
Learn more about 4506 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue